NCIt definition : An orally bioavailable imidazopyridazine and inhibitor of Janus kinase 2 mutant V617F
(JAK2V617F), with potential antineoplastic activity. Upon oral administration, gandotinib
selectively and competitively inhibits the activation of JAK2V617F, which may result
in the inhibition of the JAK-STAT signaling pathway and the induction of apoptosis
in JAK2V617F-expressing tumor cells. JAK2V617F has a substitution of phenylalanine
for valine at amino acid position 617 and plays a key role in tumor cell proliferation
and survival.;
UNII : ANC71R916O;
InChIKey : SQSZANZGUXWJEA-UHFFFAOYSA-N;
CAS number : 1229236-86-5; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1229236-86-5
alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo
G-SRS /a ;